These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31897643)

  • 1. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern.
    Servián-Morilla E; Cabrera-Serrano M; Johnson K; Pandey A; Ito A; Rivas E; Chamova T; Muelas N; Mongini T; Nafissi S; Claeys KG; Grewal RP; Takeuchi M; Hao H; Bönnemann C; Lopes Abath Neto O; Medne L; Brandsema J; Töpf A; Taneva A; Vilchez JJ; Tournev I; Haltiwanger RS; Takeuchi H; Jafar-Nejad H; Straub V; Paradas C
    Acta Neuropathol; 2020 Mar; 139(3):565-582. PubMed ID: 31897643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss.
    Servián-Morilla E; Takeuchi H; Lee TV; Clarimon J; Mavillard F; Area-Gómez E; Rivas E; Nieto-González JL; Rivero MC; Cabrera-Serrano M; Gómez-Sánchez L; Martínez-López JA; Estrada B; Márquez C; Morgado Y; Suárez-Calvet X; Pita G; Bigot A; Gallardo E; Fernández-Chacón R; Hirano M; Haltiwanger RS; Jafar-Nejad H; Paradas C
    EMBO Mol Med; 2016 Nov; 8(11):1289-1309. PubMed ID: 27807076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 (Rumi).
    Wu J; Hunt SD; Matthias N; Servián-Morilla E; Lo J; Jafar-Nejad H; Paradas C; Darabi R
    Stem Cell Res; 2017 Oct; 24():102-105. PubMed ID: 29034878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.
    Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.
    Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F
    Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylation.
    Saredi S; Gibertini S; Ardissone A; Fusco I; Zanotti S; Blasevich F; Morandi L; Moroni I; Mora M
    Eur J Paediatr Neurol; 2014 May; 18(3):404-8. PubMed ID: 24183756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy.
    Van den Bergh PYK; Sznajer Y; Van Parys V; van Tol W; Wevers RA; Lefeber DJ; Xu L; Lek M; MacArthur DG; Johnson K; Phillips L; Töpf A; Straub V
    Neuromuscul Disord; 2017 Nov; 27(11):1043-1046. PubMed ID: 28803818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation.
    Puckett RL; Moore SA; Winder TL; Willer T; Romansky SG; Covault KK; Campbell KP; Abdenur JE
    Neuromuscul Disord; 2009 May; 19(5):352-6. PubMed ID: 19342235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset limb-girdle muscular dystrophy caused by GMPPB mutations.
    Balcin H; Palmio J; Penttilä S; Nennesmo I; Lindfors M; Solders G; Udd B
    Neuromuscul Disord; 2017 Jul; 27(7):627-630. PubMed ID: 28478914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
    Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
    Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.
    Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA
    Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
    Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
    Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy.
    Godfrey C; Escolar D; Brockington M; Clement EM; Mein R; Jimenez-Mallebrera C; Torelli S; Feng L; Brown SC; Sewry CA; Rutherford M; Shapira Y; Abbs S; Muntoni F
    Ann Neurol; 2006 Nov; 60(5):603-610. PubMed ID: 17044012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biallelic variants in SNUPN cause a limb girdle muscular dystrophy with myofibrillar-like features.
    Iruzubieta P; Damborenea A; Ioghen M; Bajew S; Fernandez-Torrón R; Töpf A; Herrero-Reiriz Á; Epure D; Vill K; Hernández-Laín A; Manterola M; Azkargorta M; Pikatza-Menoio O; Pérez-Fernandez L; García-Puga M; Gaina G; Bastian A; Streata I; Walter MC; Müller-Felber W; Thiele S; Moragón S; Bastida-Lertxundi N; López-Cortajarena A; Elortza F; Gereñu G; Alonso-Martin S; Straub V; de Sancho D; Teleanu R; López de Munain A; Blázquez L
    Brain; 2024 Aug; 147(8):2867-2883. PubMed ID: 38366623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of α-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation.
    Wu B; Shah SN; Lu P; Richardson SM; Bollinger LE; Blaeser A; Madden KL; Sun Y; Luckie TM; Cox MD; Sparks S; Harper AD; Lu QL
    Am J Pathol; 2016 Jun; 186(6):1635-48. PubMed ID: 27109613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limb-girdle muscular dystrophy type 2I is not rare in Taiwan.
    Liang WC; Hayashi YK; Ogawa M; Wang CH; Huang WT; Nishino I; Jong YJ
    Neuromuscul Disord; 2013 Aug; 23(8):675-81. PubMed ID: 23800702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain.
    Munot P; McCrea N; Torelli S; Manzur A; Sewry C; Chambers D; Feng L; Ala P; Zaharieva I; Ragge N; Roper H; Marton T; Cox P; Milev MP; Liang WC; Maruyama S; Nishino I; Sacher M; Phadke R; Muntoni F
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12771. PubMed ID: 34648194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I.
    Boito CA; Fanin M; Gavassini BF; Cenacchi G; Angelini C; Pegoraro E
    Virchows Arch; 2007 Dec; 451(6):1047-55. PubMed ID: 17952692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a novel western blot assay to monitor patterns and levels of alpha dystroglycan in skeletal muscle of patients with limb girdle muscular dystrophies.
    Rajasingham T; Rodriguez HM; Betz A; Sproule DM; Sinha U
    J Muscle Res Cell Motil; 2024 Sep; 45(3):123-138. PubMed ID: 38635147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A form of muscular dystrophy associated with pathogenic variants in JAG2.
    Coppens S; Barnard AM; Puusepp S; Pajusalu S; Õunap K; Vargas-Franco D; Bruels CC; Donkervoort S; Pais L; Chao KR; Goodrich JK; England EM; Weisburd B; Ganesh VS; Gudmundsson S; O'Donnell-Luria A; Nigul M; Ilves P; Mohassel P; Siddique T; Milone M; Nicolau S; Maroofian R; Houlden H; Hanna MG; Quinlivan R; Beiraghi Toosi M; Ghayoor Karimiani E; Costagliola S; Deconinck N; Kadhim H; Macke E; Lanpher BC; Klee EW; Łusakowska A; Kostera-Pruszczyk A; Hahn A; Schrank B; Nishino I; Ogasawara M; El Sherif R; Stojkovic T; Nelson I; Bonne G; Cohen E; Boland-Augé A; Deleuze JF; Meng Y; Töpf A; Vilain C; Pacak CA; Rivera-Zengotita ML; Bönnemann CG; Straub V; Handford PA; Draper I; Walter GA; Kang PB
    Am J Hum Genet; 2021 May; 108(5):840-856. PubMed ID: 33861953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.